Scandinavian journal of gastroenterology · 2025
Development of pancreatic exocrine insufficiency after first moderately severe or severe acute pancreatitis.
СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lindström Outi, Lietzen Elina, Mentula Panu, Tolonen Matti, Siironen Päivi, Udd Marianne, Puolakkainen Pauli, Kylänpää Leena
Аннотация
OBJECTIVES: Pancreatic necrosis may develop in moderately severe and severe acute pancreatitis (AP), and result in pancreatic exocrine insufficiency (PEI). The aim of this prospective study was to investigate development of PEI in patients recovering from the first attack of moderately severe or severe AP.
MATERIALS AND METHODS: Altogether 70 patients were recruited. The development of PEI was determined by measuring the fecal elastase-1 (FE-1) during the hospitalization time, and in the follow up period 1-2 months and 12 months after discharge. Persistent PEI was defined as FE-1 level below 200 µg/g at 12 months follow up.
RESULTS: 52 patients completed the study. The median age was 53 years, 65% were male, and 63% had severe AP. The most common etiology was alcohol (58%). After 12 months of discharge the FE-1 values were normal in 67% of patients, showed moderate insufficiency in 6% and severe insufficiency in 27% of patients. For pancreatic function there was a tendency to recover in one year follow up. However, four (17%) patients with initially normal FE-1 level developed persistent PEI, whereas three (25%) and eight (57%) patients with initially moderate or severe insufficiency, had persistent PEI at 12 months. During hospitalization new onset diabetes, extent (>50%) and anatomical site (body) of pancreatic necrosis, and low FE-1 level (median 28 µg/g, range 15-161) were predictive for persistent PEI at 12 months.
CONCLUSION: Around a third of patients with first attack of moderately severe or severe AP develop PEI.
REGISTERED IN: ClinicalTrials.gov (NCT02563080).ClinicalTrials.gov identifier: NCT02563080.
MATERIALS AND METHODS: Altogether 70 patients were recruited. The development of PEI was determined by measuring the fecal elastase-1 (FE-1) during the hospitalization time, and in the follow up period 1-2 months and 12 months after discharge. Persistent PEI was defined as FE-1 level below 200 µg/g at 12 months follow up.
RESULTS: 52 patients completed the study. The median age was 53 years, 65% were male, and 63% had severe AP. The most common etiology was alcohol (58%). After 12 months of discharge the FE-1 values were normal in 67% of patients, showed moderate insufficiency in 6% and severe insufficiency in 27% of patients. For pancreatic function there was a tendency to recover in one year follow up. However, four (17%) patients with initially normal FE-1 level developed persistent PEI, whereas three (25%) and eight (57%) patients with initially moderate or severe insufficiency, had persistent PEI at 12 months. During hospitalization new onset diabetes, extent (>50%) and anatomical site (body) of pancreatic necrosis, and low FE-1 level (median 28 µg/g, range 15-161) were predictive for persistent PEI at 12 months.
CONCLUSION: Around a third of patients with first attack of moderately severe or severe AP develop PEI.
REGISTERED IN: ClinicalTrials.gov (NCT02563080).ClinicalTrials.gov identifier: NCT02563080.